In light of the current findings of network pharmacology, PIK3CA, AKT1, MAPK9, PRKCD, BRAF, IGF1R, and NOS3 were chosen as the seven key target proteins closely related to the progression of RA. Here, PRKCD is linked to rheumatoid arthritis.